|
ÅðÇ༺ ½Å°æÁúȯ Ä¡·á¾àÀÇ °³¹ß µ¿Çâ°ú °æÇÕ, Àü·«Àû Æ÷Áö¼Å´×°ú ÇÔ²² ½ÃÀå ¼ºÀå±âȸ, ÀÓ»ó½ÃÇè µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù.
1. °³¿ä
- Á¶»ç¹æ¹ý
- ÅðÇ༺ ½Å°æÁúȯ ½ÃÀå µ¿Çâ
- ¹æ¹ý·Ð°ú Á¤ÀÇ
2. ¾ËÃ÷ÇÏÀ̸Ӻ´
- ¾Æ¼¼Æ¿Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦ ¾ïÁ¦Á¦
- NMDA ±æÇ×Á¦
- ¾Æ¹Ð·ÎÀÌµå º£Å¸ Ä¡·á
- Bapineuzumab
- LY450139
- LY2062430
- ACC-001
- ±âŸ ¾ËÃ÷ÇÏÀ̸Ӻ´ Ä¡·á
3. ´Ù¹ß¼º°æÈÁõ
- ÀÎÅÍÆä·Ð º£Å¸
- ¸é¿ªÁ¶ÀýÁ¦
- Copaxone
- Fingolimod/FIY720
- BG-12
- Laquinimod
- °æ±¸ Leustatin
- Teriflunomid/HMR1726
- ´ÜÀÏŬ·ÐÇ×ü
- HuMax-CD20
- Campath
- Rituxan/MabThera
- Tysabri/Antegren
- Firategrast/SB683699
- ±âŸ Ä¡·á¹ý
4. ÆÄŲ½¼º´
- µµÆÄ¹Î ÀÛ¿ë¾à
- Comtan
- mirapex
- Sinemet
- Apokyn
- Requib XL
- ±âŸ Ä¡·á¹ý
- Azilect/Agilect
- ACP-103
- Droxidopa
ksm
|